Search Within

Principal Biostatisticians

  1. "Gynecology Disease Management Team "
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (6)
  2. Epidemiology and Biostatistics (6)
  3. Gynecology Disease Management Team (6)
  4. Solid Tumor Oncology Division (6)
  5. GDMT, Medicine (5)
  6. Gynecologic Medicine Service (5)

More Groups

People
  1. Esther Drill (5)
  2. Rachel Grisham (4)
  3. Carol Aghajanian (3)
  4. Mark Robson (2)
  5. Achim Jungbluth (1)
  6. Ahmet Zehir (1)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. American Journal of Surgical Pathology (1)
  3. Cancer Epidemiology Biomarkers and Prevention (1)
  4. Clinical Cancer Research (1)
  5. International Journal of Gynecological Cancer (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Lippincott Williams & Wilkins (2)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular results and potential biomarkers identified from the phase 3 MILO/ENGOT-ov11 study of binimetinib versus physician choice of chemotherapy in recurrent low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Vergote, I.; Banerjee, S.; Drill, E.; Kalbacher, E.; Mirza, M. R.; Romero, I.; Vuylsteke, P.; Coleman, R. L.; Hilpert, F.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Molecular results and potential biomarkers identified from MILO/ENGOT-ov11 phase 3 study of binimetinib versus physicians choice of chemotherapy (PCC) in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Grisham, R. N.; Vergote, I.; Banerjee, S. N.; Drill, E. N.; Fabbro, M.; Mirza, M. R.; Romero, I.; Coleman, R. L.; Oza, A. M.; Hilpert, F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • PD-L1 expression in metaplastic breast carcinoma using the PD-L1 SP142 assay and concordance among PD-L1 immunohistochemical assays
    Journal Article

    Grabenstetter, A.; Jungbluth, A. A.; Frosina, D.; Hoda, R.; Dos Anjos, C. H.; Patil, S.; Sevilimedu, V.; Weigelt, B.; Reis-Filho, J. S.; Zhang, H.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • MILO/ENGOT-ov11: Binimetinib versus physician’s choice chemotherapy in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
    Journal Article

    Monk, B. J.; Grisham, R. N.; Banerjee, S.; Kalbacher, E.; Mirza, M. R.; Romero, I.; Vuylsteke, P.; Coleman, R. L.; Hilpert, F.; Oza, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • MILO/ENGOT-ov11: Phase-3 study of binimetinib versus physician's choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
    Meeting Abstract

    Grisham, R.; Monk, B. J.; Banerjee, S.; Coleman, R. L.; Oza, A. M.; Oehler, M. K.; Kalbacher, E.; Mirza Raza, M.; del Campo, J. M.; Marth, C.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save